Yasemin Kemal Selected Research

Yasemin Kemal Research Topics

3	Breast Neoplasms (Breast Cancer) 02/2024 - 05/2015
3	Neoplasms (Cancer) 01/2022 - 03/2016
3	Neoplasm Metastasis (Metastasis) 01/2018 - 05/2015
2	Inflammation (Inflammations) 02/2022 - 01/2022
2	Vomiting 01/2022 - 03/2015
2	Nausea 01/2022 - 03/2015
2	Stomach Neoplasms (Stomach Cancer) 10/2015 - 01/2014
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2022
1	Alopecia (Baldness) 01/2022
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2022
1	Thyroid Neoplasms (Thyroid Cancer) 01/2022
1	Myalgia 01/2022
1	Anemia 01/2022
1	Laryngeal Neoplasms (Laryngeal Cancer) 08/2019
1	Adenocarcinoma 10/2015
1	Colorectal Neoplasms (Colorectal Cancer) 03/2015

2	ErbB Receptors (EGF Receptor)IBA 02/2024 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 02/2022 - 01/2022
2	Docetaxel (Taxotere)FDA Link 01/2022 - 01/2014
2	Cisplatin (Platino)FDA LinkGeneric 10/2015 - 01/2014
1	Hormones (Hormone)IBA 02/2024
1	palbociclibIBA 02/2024
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 02/2024
1	ribociclibIBA 02/2024
1	atezolizumabIBA 12/2022
1	Trastuzumab (Herceptin)FDA Link 01/2022
1	IodineIBA 01/2022
1	pertuzumabIBA 01/2022
1	Formaldehyde (Formol)FDA Link 08/2019
1	ParaffinIBA 08/2019
1	epithelial membrane protein-1IBA 03/2016
1	Capecitabine (Xeloda)FDA Link 10/2015
1	Peroxidase (Myeloperoxidase)IBA 05/2015
1	Monoclonal AntibodiesIBA 03/2015
1	Fluorouracil (Carac)FDA LinkGeneric 01/2014
1	Epirubicin (Ellence)FDA LinkGeneric 01/2014